Shanghai Runda Med Tech Co (603108) — Capital Reinvestment Ratio

Latest as of June 2023: 0.47x

Shanghai Runda Med Tech Co (603108) has a Capital Reinvestment Ratio of 0.47x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥144.38 Million) in capital expenditures (CN¥68.54 Million). See Shanghai Runda Med Tech Co (603108) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.47x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥144.38 Million
CNY

Capital Expenditures

CN¥68.54 Million
CNY

Data as of

Jun 2023
Most recent filing

Shanghai Runda Med Tech Co Capital Reinvestment Ratio (2014–2024)

This chart tracks Shanghai Runda Med Tech Co's Capital Reinvestment Ratio across 7 annual periods. Check 603108 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shanghai Runda Med Tech Co (2014–2024)

Year-by-year Capital Reinvestment Ratio for Shanghai Runda Med Tech Co from 2014 to 2024. For live market cap and broader valuation context, see 603108 stock market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.35x CN¥646.95 Million CN¥229.16 Million ▼ -19.2%
2023 0.44x CN¥729.72 Million CN¥319.88 Million ▼ -46.0%
2021 0.81x CN¥371.11 Million CN¥301.09 Million ▼ -20.9%
2020 1.03x CN¥323.44 Million CN¥331.94 Million ▼ -12.3%
2019 1.17x CN¥246.68 Million CN¥288.73 Million ▲ +138.5%
2018 0.49x CN¥538.90 Million CN¥264.43 Million ▼ -85.9%
2014 3.47x CN¥36.11 Million CN¥125.35 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow